Michael Simmons, MLS

Article

For those intolerant to ACE inhibitors and ARBs, what is the best therapy for reducing the risk of diabetic nephropathy?

Author:: Michael Simmons, MLS

Publish date: August 1, 2005

EVIDENCE-BASED ANSWER: Angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) are the first-line agents for reduci...